IBRX

ImmunityBio, Inc. Common Stock

9.91

USD

+0.16

+1.64%

Oct 08, 15:59 UTC -4

Closed

After-Market

9.90

-0.01

-0.14%

ImmunityBio, Inc. Common Stock Profile

About

ImmunityBio Inc. is a late-clinical-stage immunotherapy company developing therapies which drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems. ImmunityBio Inc., formerly known as NantKwest Inc., is based in CULVER CITY, Calif.

Info & Links

CEO

Richard Adcock

Headquarters

3530 JOHN HOPKINS COURT
SAN DIEGO, CA 92121, UNITED STATES

Auditor

Ernst & Young LLP

Share holders

Employees

691

ImmunityBio, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization²

10.49B

Enterprise Value

11.19B

Enterprise Value/EBITDA(ttm)

-47.56

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

61.94

Price to Book(mrq)

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

99.33%

Operating Margin(ttm)

-178.81%

Profit Margin(ttm)

-563.15%

Return on Equity(ttm)

Return on Invested Capital(ttm)

989.84%

Return on Assets(ttm)

-51.65%

Income Statement

Revenue(ttm)

165.79M

Revenue Per Share(ttm)

0.16

Gross Profit(ttm)

164.70M

EBITDA(ttm)³

-235.20M

Net Income Available to Common(ttm)

-992.36M

Diluted EPS(ttm)

-0.97

Share Statistics

Beta (5Y Monthly)

0.02

52-Week Change

296.40%

S&P 500 52-Week Change

20.97%

S&P 500 Member

Stock Optionable

Yes

Total Shares Outstanding¹

1.06B

Dividend Yield

0.00%

Float⁴

359.28M

% Held by Insiders

66.10%

% Held by Institutions

8.58%

Balance Sheet

Total Cash(mrq)

357.37M

Total Cash Per Share(mrq)

0.34

Total Debt(mrq)

774.35M

Total Debt/Equity(mrq)

-74.05%

Current Ratio(mrq)

5.72%

Quick Ratio(mrq)

5.70%

Book Value Per Share(mrq)

-0.99

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.14

Free Cash Flow(ytd)

-147.15M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.